DUBLIN--(BUSINESS WIRE)--The "Global Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End-user (Pharma, Biotech), and Region - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period.
The instruments segment will grow at the highest rate during the forecast period
On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2021, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2021
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types.
The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2021.The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020-2027)
North America accounted for the largest share of the nucleic acid isolation and purification market in 2021. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America.
On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
Market Dynamics
Drivers
- Increasing R&D Activities
- Technological Advancements and Increasing Automation
Restraints
- High Cost of Automated Instruments
Opportunities
- High Scope of Growth in Emerging Economies
- Improving Regulatory and Reimbursement Scenario
- Molecular Diagnostics and Personalized Medicine
Trends
- Increase in Government Funding
Companies Mentioned
- 3D Blackbio Biotech India Ltd.
- Agilent Technologies, Inc.
- Analytik Jena AG
- Bio-Rad Laboratories, Inc.
- Biovision
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Genaxxon Bioscience GmbH
- General Electric Company
- Illumina, Inc.
- Invitek Molecular GmbH
- Merck KGaA
- New England Biolabs
- Norgen Biotek
- Omega Bio-Tek, Inc.
- Promega Corporation
- Qiagen
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Zymo Research
For more information about this report visit https://www.researchandmarkets.com/r/pdt4js
